The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Stealth BioTherapeutics Corp(NASDAQ:MITO) 
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate, Elamipretide, has the potential to treat rare genetic and common age-related m...
Website: http://www.stealthbt.com
Founded: 2006
Full Time Employees: 29 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Stealth BioTherapeutics Corp Op Cashflow Per Share ttm
Stealth BioTherapeutics Corp Free Cashflow Per Share ttm
Stealth BioTherapeutics Corp Cash Per Share ttm
Stealth BioTherapeutics Corp P/S ratio ttm
Stealth BioTherapeutics Corp (GAAP) P/E ratio ttm
Stealth BioTherapeutics Corp P/B ratio ttm
No extra charts and metrics for this ticker.